// App-Quantinova.ai

12063 : Integration of a polygenic risk score of kidney function with cumulative cisplatin dose and time variables for the prediction of serum platinum levels.

Researchers

Presenter

  • Megan Shuey

Principal Investigators

  • Annika Faucon

  • Matthew R. Trendowski

  • Mark J. Ratain

  • Paul C Dinh

  • Darren R. Feldman

  • Robert James Hamilton

  • David J. Vaughn

  • Chunkit Fung

  • Christian K. Kollmannsberger

  • Robert A Huddart

  • Neil E. Martin

  • Robyn Hannigan

  • Lawrence H. Einhorn

  • Lois B. Travis

  • M. Eileen Dolan

  • Nancy Cox

Medical Centers

  • Vanderbilt University Medical Center, Nashville, TN

  • Vanderbilt University, Nashville, TN

  • Department of Health Studies, The University of Chicago, Chicago, IL

  • The University of Chicago Medical Center, Chicago, IL

  • Indiana University School of Medicine, Indianapolis, IN

  • Memorial Sloan Kettering Cancer Center, Port Washington, NY

  • Division of Gynecologic Oncology, Princess Margaret Cancer Centre/University Health Network/Sinai Health Systems, Toronto, ON, Canada

  • Canada.

  • Department of Medicine, University of Pennsylvania, Philadelphia, PA

  • James P. Wilmot Cancer Institute, University of Rochester Medical Center,

  • Division of Hematology, University of British Columbia, Vancouver, BC, Canada

  • The Institute of Cancer Research, The Royal Marsden NHS Foundation Trust, Sutton, United Kingdom

  • Dana-Farber Cancer Institute, Boston, MA

  • Clarkson University, Potsdam, NY.

  • Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, IN

  • Department of Radiology, University of Chicago, Chicago, IL

Locations

  • United States

  • Canada

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Nephrology

  • Oncology (ONC)

Disease

  • Chronic kidney disease

  • Testicular cancer

  • Renal disease

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • Cisplatin

Outcome

  • N/A


Study Design

  • Multicenteric

  • Cohort

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A